Table 4. Gleheda binding to the Consortium glycan (glycotope) array.

Spacer definitions and entire glycan array version at http://www.functionalglycomics.org/static/consortium/. PAA, polyacrylamide conjugate; BT, biotin conjugate.

Glycan no.	Glycan (glycotope)–spacer	Glycotope abbreviation	S/N
High affinity (S/N was greater than 3 times the average S/N for the entire array)
135	GalNAcα1-3Gal–Sp2	A disaccharide	110.03
8	α-GalNAc–Sp2	α-GalNAc	101.02
30	Galα1-4Galβ1-4Glcβ–Sp1	Pk; (ELβ Tri-)	75.88
4	α-D-Gal–Sp2	Galα1-	75.33
64	Galα1-3Galβ–Sp2	B disaccharide	71.07
193	Galα1-3Galβ1-4Glcβ–Sp1	Galili Tri; (BL Tri-)	62.93
9	β-GalNAc–Sp2	β-GalNAc	58.25
31	Galα1-4Galβ1-4GlcNAcβ–Sp1	P1; (EIIβ)	49.07
134	Galα1-2Galβ–Sp2	Galα1-2Gal	46.78
167	Galα1-3Galβ1-4(Fucα1-3)GlcNAcβ–Sp2	αGalLex; (BII/Lex Tetra-)	42.14
138	Galα1-3Galβ1-4GlcNAcβ–Sp2	Galα1-3′LacNAc; (BIIβ Tri-)	36.69
65	Galβ1-2Galβ–Sp2	Galβ1-2Gal	35.50
22	GalNAcβ1-4GlcNAcβ–Sp2	Lac-di-NAc	34.51
82	GalNAcα1-3(Fucα1-2)Galβ–Sp7	Atri-long; (Ah)	31.56
Medium affinity (S/N was greater than 2 times the average S/N for the entire array)
172	GalNAcα1-3(Fucα1-2)Galβ1-4GlcNAcβ–Sp2	A type II; (AhII β)	17.74
63	6-Su-GalNAcα–Sp2	α-GalNAc-6-sulphate	16.54
67	Galβ1-4(6-O-Su)GlcNAcβ–Sp2	6′-O-su-LacNAc	14.86
Low affinity (S/N was greater than the average S/N for the entire array)
112	GalNAcβ1-4GlcNAcβ1-4Manα1-6(GalNAcβ1-4GlcNAcβ1-	Bi-LDN (remodelled from human fibrinogen)	12.91
	4Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAcβ-N–Sp
203	GalNAcα1-3(Fucα1-2)Galβ1-4GlcNAc–SP1.BT	A-tetra type II; (AhII Tetra-)	10.98
26	GalNAcβ1-4(Fucα1-3)GlcNAc–Sp1	Fucα1-3-Lac-di-NAc	10.38
91	α-D-Gal-PAA–Sp1	α-D-galactose	9.86
77	Galα1-3(Fucα1-2)Galβ–Sp7	Btri-long; (Bh)	9.58
93	α-GalNAc-PAA–Sp1	α-GalNAc	9.32
202	GalNAcα1-3(Fucα1-2)Galβ1-4Glc–SP1.BT	A-tetra Lac; (AhL Tetra-)	7.32